Pediatr. praxi. 2013;14(5):331-332

New possibilities in medical treatment of acute diarrhea in pediatric patients: racecadotril - an enkephalinase inhibitor

MUDr.Peter Szitányi, Ph.D.
Klinika dětského a dorostového lékařství 1. LF UK a VFN, Praha

Acute gastroenteritis represents one of the most frequent diseases in pediatric patients. Racecadotril is a new drug, which increases therapeutic

possibilities of pediatric diarrhea. The use of racecadotril in combination with oral rehydration solutions (ORS) is recommended

for treatment of acute gastroenteritis.

Keywords: acute gastroenteritis, racecadotril

Published: October 24, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Szitányi P. New possibilities in medical treatment of acute diarrhea in pediatric patients: racecadotril - an enkephalinase inhibitor. Pediatr. praxi. 2013;14(5):331-332.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schwartz JC. Racecadotril: a new approach to the treatment of diarrhoea. Int J Antimicrob Agents, 2000; 14: 75-79. Go to original source... Go to PubMed...
    2. Alvarez GC, Simon GP, Castro LT, et al. Effectiveness of racecadotril in the treatment of acute gastroenteritis. Acta Pediatr Esp. 2009; 67(3): 117-122.
    3. Guarino A, et al. ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. JPGN 2008; 46: S81-122. Go to original source... Go to PubMed...
    4. Cezard JP, Duhamel JF, Meyer M, et al. Efficacy and tolerability of racecadotril in acute diarrhoea in children. Gastroenterology 2001; 120: 799-805. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.